Company / Revenue
CAPRICOR THERAPEUTICS, INC. Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
-
FY2025
5-year range
$0 / $25.2M
FY2021-FY2025
Trend
-100.0%
vs FY2024
Sector context
#148 of 155
Health Care
What the data says
Declined from $25M to $0 over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 155
▼
Key checks
Key Insights
- In FY2025, revenue decreased 100.0% year-over-year.
- Peak revenue was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0 | -100.0% |
| FY2024 | $22.3M | -11.5% |
| FY2023 | $25.2M | +886.8% |
| FY2022 | $2.6M | +941.8% |
| FY2021 | $244.9K | -21.1% |
| FY2020 | $310.3K | -81.4% |
| FY2019 | $1.7M | +0.0% |
| FY2018 | $1.7M | -37.3% |
| FY2017 | $2.7M | -33.3% |
| FY2016 | $4.0M | -27.5% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026